Predictive value of the HIV paediatric classification system for the long-term course of perinatally infected children
Background To compare the Centers for Disease Control and Prevention (CDC) paediatric classification system with the long-term course of perinatal human immunodeficiency virus type 1 (HIV-1) infection. Methods Prospective study on 366 perinatally infected children followed-up from birth and checked...
Gespeichert in:
Veröffentlicht in: | International journal of epidemiology 2000-06, Vol.29 (3), p.573-578 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background To compare the Centers for Disease Control and Prevention (CDC) paediatric classification system with the long-term course of perinatal human immunodeficiency virus type 1 (HIV-1) infection. Methods Prospective study on 366 perinatally infected children followed-up from birth and checked at least every 2 months. Survival, smoothed hazard, adjusted hazard ratio of death, and transition probabilities in clinical and immunological categories were outcome measures. Results Survival was 49% (95% CI : 40–58%) at 8 years. The risk of death was high before the age of 2, relatively low between ages 2 and 7, and contained thereafter. Children did not advance through the categories sequentially. Survival at 8 years was 61.7% (95% CI : 49.8–73.6%) in those children who had passed through clinical category A; the hazard ratio of death was 2.5 (95% CI : 1.7–3.8) for 175 (47.9%) children who skipped this category. Transition probability in clinical category B was 39.9% (95% CI : 32.3–45.6%) after one year, but 59.1% (95% CI : 51.4–66.8%) after 5 years. Before 2 years of age, the probability of entry into category C (40%; 95% CI : 35–45%) was higher than that of entry into immunological category 3 (28%; 95% CI : 22–34%). Conclusions The classification system stands comparison with the clinical reality, but the CD4-positive cell thresholds in infancy should be adjusted and category B indicator diseases better distributed to improve their predictive value. |
---|---|
ISSN: | 0300-5771 1464-3685 1464-3685 |
DOI: | 10.1093/ije/29.3.573 |